echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Puli Pharmaceutical's Esomeprazole Sodium for Injection was officially approved by the FDA

    Puli Pharmaceutical's Esomeprazole Sodium for Injection was officially approved by the FDA

    • Last Update: 2022-05-29
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On February 14, Puli Pharmaceuticals announced that it had recently received a marketing approval notice for generic esomeprazole sodium for injection issued by the US FDA
    .
    Indications are: 1.
    As an alternative therapy for the short-term treatment of gastroesophageal reflux disease (GERD) with erosive esophagitis (EE) in adults and children aged 1 month to 17 years when oral therapy is not appropriate

    .
    2.
    Reduce the risk of rebleeding after therapeutic endoscopy for acute bleeding of gastric or duodenal ulcers in adults

    .

    Esomeprazole, also known as esomeprazole, is a single levorotatory isomer of omeprazole, both of which are proton pump inhibitors, which can effectively inhibit gastric acid secretion and are clinically used for the treatment of gastroesophageal reflux disease.
    Fluid disease, erosive reflux esophagitis,

    etc.

    The drug is one of the most successful examples of isomer development, with stronger gastric acid inhibition and fewer adverse reactions than the first-generation omeprazole
    .
    It was first developed by AstraZeneca, and its oral preparation was launched in Sweden in 2000 under the trade name of Nexium.
    Its injection was launched in 2003 and was approved by the US Food and Drug Administration (FDA) in March 2005

    .

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.